Acute tumor lysis syndrome secondary to hydroxycarbamide in chronic myelomonocytic leukemia [5]

American Journal of Hematology

Volumn 81, Issue 3, 2006, Pages 220-221

  Otrock, Zaher K ^a   Taher, Ali T ^a   Mahfouz, Rami A R ^a   Makarem, Jawad A ^a   Shamseddine, Ali I ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALI; ALLOPURINOL; BICARBONATE; CREATININE; CYTOTOXIC AGENT; GLUCOSE; HYDROXYUREA; INSULIN; LACTATE DEHYDROGENASE; PHOSPHORUS; POLYSTYRENESULFONATE SODIUM;

ADULT; ALKALINIZATION; CASE REPORT; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL FEATURE; DISEASE COURSE; FLUID THERAPY; HUMAN; LETTER; MALE; PATIENT MONITORING; PRIORITY JOURNAL; TUMOR LYSIS SYNDROME;

ANTINEOPLASTIC AGENTS; HUMANS; HYDROXYUREA; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MALE; MIDDLE AGED; TUMOR LYSIS SYNDROME;

EID: 33644514950     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20497     Document Type: Letter

References (5)

1. Chasty RC, Liu-Yin JA. Acute tumour lysis syndrome. Br J Hosp Med 1993;49: 488-492.
2. Onida F, Kantarjian HM, Smith TL, et al. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. Blood 2002;99:840-849.
3. Hande KR, Garrow GC. Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma. Am J Med 1993;94:133-139.
4. Razis E, Arlin ZA, Ahmed T, et al. Incidence and treatment of tumor lysis syndrome in patients with acute leukemia. Acta Haematol 1994;91:171-174.
5. Sullan S. Management of acute tumor lysis syndrome. Semin Oncol 2001;28(2 Suppl 5):9-12.